CoChat

HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents

Open access
Chen, X. · 2005 · Journal of Neuroscience
Cited by 81

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

1056 Objectives: Ascorbate is a water-soluble antioxidant vitamin. Emerging clinical studies have used ascorbate as a cancer chemotherapeutic agent, and to ameliorate chemotherapy-induced side effects in several types of cancers, including glioblastoma, head and neck squamous cell carcinoma (HNSCC), prostate cancer (PCa) and breast cancer. Although hundreds of patients receive ascorbate treatments for advanced cancers, only a few have achieved an anticancer response. Proactively identifying those who will respond to a given treatment will help clinicians provide the right therapeutic alternatives. However, it is unclear how ascorbate works in reactive oxygen species (ROS) environments in tumor cells. We recently reported the design, synthesis, automated radiochemical production of [18F]KS1, a fluroethoxy-ascorbate derivative and its initial in vitro and in vivo PET imaging in PCa tumor-bearing mice.1 Herein, we describe the ROS-tracking properties of KS1 at tracer levels and suppression of tumor growth in cancer cells at pharmacologic doses. We also report the PET imaging properties of [18F]KS1 in a murine model of HNSCC. Methods: We used DCFDA ROS detection assay kit using the antibody, ab113851 to demonstrate the ROS generation property of KS1. Both SCC-61, a radiation-sensitive HNSCC cell line and PC3, a PCa cell line were incubated with KS1 and ascorbate at 10 µM and 100 µM for 7 h. The same assay was repeated with 0.1 mM and 2 mM of KS1 and ascorbate (n=6). The kit uses tert-butyl hydrogen peroxide, a common ROS inducer as a positive control, and N-acetyl cysteine, a common ROS suppressor as a negative control. ROS intensity was analyzed on a Tecan fluorescent reader and the data was expressed as mean fluorescent values ± SD (n=6). MicroPET imaging and biodistribution studies were performed in SCC-61 and rSCC-61 (radiation-sensitive and radiation-resistant HNSCC respectively) tumor-bearing mice (n=5) for 20 min after 45 min [18F]KS1 post-injection. Results: KS1 at 10 µM and 100 µM did not generate any ROS in both SCC-61 and PC3 cell lines. There was no significant change in the intensity between KS1 and ascorbate KS1 intensity at 2 mM increased significantly compared to the intensity at 100 µM. The uptake was close to the positive control TBHP. More importantly, the increased uptake was lowered (~3-fold) with SOD addition. Ascorbate intensity also increased, but not as KS1. With microPET, we observed high [18F]KS1 uptake in SCC-61 vs. rSCC-61 tumors. From the basic region of interest analysis on mPET scans, ROS-expressing SCC-61 tumors showed ~1.2-fold higher tumor uptake than rSCC-61 tumors, demonstrating high target selectivity. Biodistribution results show excellent tumor to muscle ratio in SCC-61 (10.93) and rSCC-61 tumors (4.11), with ~2.5-fold enrichment in SCC-61 tumors. These biodistribution results were consistent with in vitro cell uptake and microPET/CT imaging results. Additionally, [18F]KS1’s higher tumor uptake in SCC-61 tumors establishes its validity to distinguish high from low ROS tumor tissue (see supporting info). More importantly, the radioactivity profile is similar to the distribution kinetics in normal mice at 30 min post-injection. Conclusions: KS1 do not generate ROS in tumor cells at tracer level concentrations (≤100 uM) and tumor-killing properties by inducing ROS generation at pharmacologic doses (≥1.0 mM), and behave like ascorbate. [18F]KS1 exhibited high tumor uptake in vivo, with superior specificity and selectivity, and favorable pharmacokinetics in several tumor-bearing mice. This would be the first [18F]-based PET tracer, based on a natural vitamin to image ROS in tumor cells in vivo, with a clear mechanistic profile. Based on our promising data, we hypothesize that ascorbate-based PET ligand strategy will expand the ascorbate scaffold for potential imaging agent(s) to image ROS in vivo. 1Solingapuram et al; EJNMMI 2019,9 (1), 43.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1153-05.2005

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 81

Metadata

Authors
Chen, X.
Venue
Journal of Neuroscience
Published
2005-06-15
Volume
25
Issue
24
Pages
5803-5814
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1974119455
Cited by
81
References
10
FWCI
2.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents. https://app.cochat.ai/papers/10.1523/jneurosci.1153-05.2005
The paper
Chen, X. (2005). HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.1153-05.2005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.